TABLE 2.
TRAEs During or 5 weeks After Neoadjuvant Nivolumab and Ipilumumab or Before Surgery in the Intent-to-Treat Population
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.